100 mg Azacitidine Injection

Get a Price/Quote

MOQ : 100 Packs

100 mg Azacitidine Injection Specification

Indication
Treatment of Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia (AML)

Salt Composition
Azacitidine 100 mg

Dosage Form
Lyophilized Powder for Injection

Feature
Sterile, single use only; antineoplastic cytotoxic agent

Ingredients
Azacitidine, Excipients

Application
Parenteral use only, administered by subcutaneous or intravenous injection

Ph Level
Not specified (typically reconstituted for injection with normal saline at pH 6-7)

Physical Color/Texture
White to off-white lyophilized powder

Fermentation Smell
Odorless

Storage Instructions
Store below 25C; protect from light; after reconstitution, use immediately or store under refrigeration (2C - 8C) up to 22 hours

Shelf Life
24 months

Administration Route
Subcutaneous or intravenous injection

Pack Size
Single-use vial containing 100 mg Azacitidine

Reconstitution
Reconstitute with 4 mL sterile water for injection

Prescription Requirement
Prescription only (Rx)

Marketed By
As per local distributor

Hazardous Drug Handling
Use appropriate precautions during handling and administration

100 mg Azacitidine Injection Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About 100 mg Azacitidine Injection

Experience pivotal treatment with our 100 mg Azacitidine Injection, an outstanding and cost-effective solution for Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia (AML). Packaged as a single-use vial with lyophilized powder, it assures competitive pricing and monumental reliability in cancer care. Easy to reconstitute with 4 mL sterile water and suitable for subcutaneous or intravenous routes, it is available strictly by prescription and must be handled with standard hazardous drug precautions. Try now for effective outcomes. Store below 25C and use promptly after reconstitution.

Features and Application of 100 mg Azacitidine Injection

The Azacitidine Injection comes as a sterile, lyophilized powder in a single-use vial, ensuring safe, precise dosing each time. Designed for parenteral use, it can be administered via subcutaneous or intravenous injection, offering convenient options for oncologists and healthcare professionals. The product is odorless with a white to off-white appearance, making it easy to handle and reconstitute with sterile water. Its antineoplastic cytotoxic property makes it indispensable in cancer treatment regimens.

Shipment, Valuation, and Export Details

Delivery of the 100 mg Azacitidine Injection is prompt, facilitated by a robust goods transport network to ensure fast and safe arrival at your destination. Valuation is transparent and competitive, reflecting its quality and efficacy. Exports cater mainly to international markets, with India as a pivotal supplier and trader. Sample policies are accommodating, allowing healthcare providers to review product quality before making large-volume purchase decisions.

FAQ's of 100 mg Azacitidine Injection:

Q: How should the 100 mg Azacitidine Injection be reconstituted before administration?

A: Reconstitute the lyophilized powder in the 100 mg Azacitidine single-use vial with 4 mL of sterile water for injection, following recommended safety protocols.

Q: What is the primary usage of Azacitidine 100 mg Injection?

A: This injection is indicated for the treatment of Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia (AML) and is administered by healthcare professionals.

Q: When should the reconstituted Azacitidine solution be used?

A: After reconstitution, the solution should be used immediately or stored under refrigeration (2C - 8C) for up to 22 hours to maintain potency.

Q: Where can the product be exported and who is the main supplier?

A: This product is exported worldwide with India being a pivotal supplier and trader as per local distributor arrangements.

Q: What precautions are necessary during the handling and administration process?

A: Due to its classification as a hazardous drug, use appropriate personal protective equipment and follow standard safety protocols while handling and administering the injection.